Page last updated: 2024-10-21

tacrine and Movement Disorders

tacrine has been researched along with Movement Disorders in 2 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohan, M1
Yarlagadda, S1
Chintala, S1
Salamone, JD1
Carlson, BB1
Rios, C1
Lentini, E1
Correa, M1
Wisniecki, A1
Betz, A1

Other Studies

2 other studies available for tacrine and Movement Disorders

ArticleYear
Effect of ethanolic extract of Coriandrum sativum L. on tacrine induced orofacial dyskinesia.
    Indian journal of experimental biology, 2015, Volume: 53, Issue:5

    Topics: Animals; Behavior, Animal; Brain; Coriandrum; Lipid Peroxidation; Movement Disorders; Oxidative Stre

2015
Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243.
    Behavioural brain research, 2005, Jan-30, Volume: 156, Issue:2

    Topics: Analysis of Variance; Animals; Cholinergic Agents; Disease Models, Animal; Dopamine Agonists; Dose-R

2005